Home › Cirrhosis
Pag-aaral pangklinika para sa Cirrhosis na nagre-recruit sa U.S.
37 pag-aaral para sa Cirrhosis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA9 pag-aaral
- Cleveland, OH9 pag-aaral
- Dallas, TX9 pag-aaral
- Houston, TX8 pag-aaral
- Miami, FL7 pag-aaral
- San Antonio, TX7 pag-aaral
- Los Angeles, CA6 pag-aaral
- New York City, NY5 pag-aaral
- Rochester, MN4 pag-aaral
- San Diego, CA4 pag-aaral
- Durham, NC4 pag-aaral
- Indianapolis, IN4 pag-aaral
- Chicago, IL4 pag-aaral
- Nashville, TN4 pag-aaral
- New Orleans, LA4 pag-aaral
- Round Rock, TX4 pag-aaral
- Baltimore, MD4 pag-aaral
- Richmond, VA3 pag-aaral
- Minneapolis, MN3 pag-aaral
- Philadelphia, PA3 pag-aaral
- Austin, TX3 pag-aaral
- Doral, FL3 pag-aaral
- Arlington, TX3 pag-aaral
- Tucson, AZ3 pag-aaral
- Chandler, AZ3 pag-aaral
- Columbus, OH3 pag-aaral
- Tampa, FL3 pag-aaral
Ayos sa estado
- Arizona6 pag-aaral
- California11 pag-aaral
- Colorado3 pag-aaral
- Florida9 pag-aaral
- Georgia3 pag-aaral
- Illinois4 pag-aaral
- Indiana5 pag-aaral
- Kansas3 pag-aaral
- Louisiana4 pag-aaral
- Maryland4 pag-aaral
- Massachusetts9 pag-aaral
- Michigan3 pag-aaral
- Minnesota7 pag-aaral
- Missouri3 pag-aaral
- New York6 pag-aaral
- North Carolina6 pag-aaral
- Ohio12 pag-aaral
- Pennsylvania6 pag-aaral
- Tennessee6 pag-aaral
- Texas15 pag-aaral
- Virginia3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07325526Endoscopic Ultrasound Shear Wave Elastography Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06592820Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07631637Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07854782High Dose Albumin in Refractory Ascites
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05867602Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07610837LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06632444Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07122700Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT01757730Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06265272HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05205954Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05028829Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05832229HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis
Nagre-recruit
Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05166499Molecular Mechanism of Exercise in Cirrhosis
Nagre-recruit
Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05982769National Liver Cancer Screening Trial
Nagre-recruitPhase 4
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06084234Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT03208868Fibrosis Lessens After Metabolic Surgery
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT06374875Measuring Patient Reported Needs in Outpatient Liver Disease Management
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07191886Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05181826Multi-analyte Blood Test Clinical Trial
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05199259Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT06138821Digoxin In NASH (CODIN)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update May 26, 2026 · NCT06588699Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update May 7, 2026 · NCT06950788COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT05692024Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.